Andra Balanescu Selected Research

MDX-1100

6/2012

A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andra Balanescu Research Topics

Disease

8	Rheumatoid Arthritis 01/2021 - 01/2009
5	Psoriatic Arthritis 11/2021 - 01/2009
4	Pain (Aches) 11/2021 - 01/2018
4	Arthritis (Polyarthritis) 01/2020 - 01/2009
3	Inflammation (Inflammations) 01/2020 - 01/2017
2	Disease Progression 01/2022 - 01/2014
2	Systemic Scleroderma (Systemic Sclerosis) 10/2021 - 06/2016
2	Fatigue 12/2020 - 07/2016
2	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2020 - 07/2016
2	Osteoarthritis 01/2020 - 01/2009
2	Necrosis 01/2020 - 09/2017
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Osteitis 01/2017
1	Synovitis 01/2017
1	Pulmonary Hypertension 06/2016
1	Contracture 06/2016
1	Muscle Weakness 06/2016
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2009

Drug/Important Bio-Agent (IBA)

4	ametantrone (HAQ)IBA 01/2022 - 12/2020
2	Vitamin D FDA LinkGeneric 01/2022 - 06/2016
2	Carbon MonoxideIBA 01/2022 - 06/2016
2	C-Reactive ProteinIBA 01/2022 - 07/2016
2	Rituximab (Mabthera)FDA Link 01/2021 - 09/2017
2	Biosimilar PharmaceuticalsIBA 01/2021 - 09/2017
2	Biological ProductsIBA 01/2020 - 01/2014
2	Methotrexate (Mexate)FDA LinkGeneric 09/2017 - 06/2012
1	Glucosamine (Dona)IBA 01/2022
1	ChondroitinIBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 10/2021
1	CytokinesIBA 10/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	GlucocorticoidsIBA 01/2020
1	InterleukinsIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	cetyl myristoleateIBA 01/2020
1	Antirheumatic Agents (DMARD)IBA 01/2020
1	Interleukin-12 (IL 12)IBA 01/2020
1	Prostaglandins AIBA 06/2018
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2018
1	Infliximab (Remicade)FDA Link 01/2017
1	Contrast MediaIBA 01/2017
1	GadoliniumIBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2014
1	Chemokine ReceptorsIBA 03/2013
1	ChemokinesIBA 06/2012
1	Proteins (Proteins, Gene)FDA Link 06/2012
1	MDX-1100IBA 06/2012
1	InterferonsIBA 06/2012
1	Monoclonal AntibodiesIBA 06/2012
1	Anti-Citrullinated Protein AntibodiesIBA 01/2009
1	Peptides (Polypeptides)IBA 01/2009
1	Anti-Idiotypic AntibodiesIBA 01/2009
1	AntibodiesIBA 01/2009

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2017
1	Biological Therapy 10/2020
1	Injections 01/2020